How do outcomes differ between patients with type 2 diabetes mellitus (DM) and heart disease undergoing revascularization or medical therapies?

Updated: Jul 13, 2021
  • Author: Romesh Khardori, MD, PhD, FACP; Chief Editor: George T Griffing, MD  more...
  • Print

The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) study, which was conducted in 2368 patients with type 2 diabetes mellitus and heart disease, showed no significant difference in the rates of death and major cardiovascular events between patients undergoing prompt revascularization and those undergoing medical therapy with insulin or insulin-sensitizing drugs. [355] These data emphasize the need to customize therapy to the patient’s circumstances and therapeutic goals.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!